|Mr. Giulio Cerroni||CEO & Director||537.66k||N/A||1962|
|Mr. Grant Nash||CFO, Company Sec. & Exec. Director||199.44k||N/A||N/A|
|Prof. Daniel Rueckert||Co-Founder & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Prof. Derek Lionel Glendon Hill||Co-Founder and Pres of Regulatory Science & External Relations||N/A||N/A||1966|
|Prof. David Hawkes||Co-Founder & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Prof. Joseph Hajnal||Co-Founder & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Mr. Marcus Thornton||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Mark Austin||Director of Technology||N/A||N/A||N/A|
|Ms. Hannah Esfahanian||HR Mang.||N/A||N/A||N/A|
|Dr. John Hall||Sr. VP of Bus. Devel.||N/A||N/A||1979|
IXICO plc provides data analytics services to the biopharmaceutical industry in the United States, the United Kingdom, Europe, and internationally. It provides collection, analysis, management, and reporting services on data generated in the course of a clinical study. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer. The company offers end-to-end imaging services in the fields of Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, And Progressive Supranuclear Palsy, Spinocerebellar Ataxia, and Friedreich's Ataxia diseases, as well as other movement disorders and dementias; and engages in the data collection and analysis of neurological diseases. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was incorporated in 1995 and is based in London, the United Kingdom.
IXICO plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.